BGPT: Best Evidence: TDP-43 APA cryptic polyA causality functional tests

Explore by Goal

Quick Analysis Plan Copied

The supplied evidence set does not contain direct TDP-43 alternative polyadenylation (APA) or cryptic polyadenylation causality studies; the closest adjacent functional data are splicing-defect timecourses showing spliceosomal disruption precedes TDP-43 pathology and CFTR minigene assays where dimerization-deficient TDP-43 loses splicing function that WT rescues .

Long Analysis Plan

Missing Direct Evidence: APA/Cryptic PolyA

The supplied records do not contain any alternative polyadenylation or cryptic polyadenylation experiments (e.g., STMN2/UNC13A-type cryptic exon rescue or mislocalization functional tests). What exists is adjacent: ActD timecourse data show spliceosomal/transcriptional stress monomerizes TDP-43 before mislocalization and phosphorylation, and the 6M NTD mutant loses CFTR exon-9 skipping with WT-rescuable phenotype — a functional causality test for splicing, not APA . Confounding factors for causality inference include overexpression artifacts, small postmortem cohorts (n=4 cortex, n=9 spinal cord), and non-neuronal cell models . To battle-test APA causality, cryptic-polyA-site reporter assays with TDP-43 knockdown/rescue in motor neurons are required and absent here.

Feedback:

Updated: September 20, 2026

Top Data Sources Export MCP

1. The study uncovers a functional interaction between TDP-43 and USP10, showing that USP10 modulates TDP-43 aggregation and splicing, is upregulated in ALS/FTD patient tissue, can rescue TDP-43 toxicity in vivo (Drosophila), and that TDP-43 likewise influences USP10 levels, implying a regulatory hub among TDP-43, USP10, and G3BP1 that affects stress granule dynamics and splicing. [2024]

9QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

2. The study demonstrates that monomerization of TDP-43, driven by loss of N-terminal dimerization, triggers cytoplasmic mislocalization, phosphorylation, and aggregation to form TDP-43 pathology in ALS, and introduces a reversible TDP-43 dimerization reporter (TDP-DiLuc) to reveal that spliceosomal/spliceosomal integrity defects and transcriptional stress disrupt TDP-43 dimerization, uncovering monomerization as an early determinant of TDP-43 pathology. [2023]

9QualityResults Limitations Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. The study uses CRISPR-tagged endogenous TDP-43 in human cells to show that oxidative stress and acetylation-mimicking or RNA-binding-deficient TDP-43 assemblies sequester endogenous normal nuclear TDP-43 into nuclear and cytoplasmic pathological structures, depleting the functional nuclear pool, altering solubility and mobility, and highlighting distinct pathways by which TDP-43 dysfunction may initiate ALS/FTD pathology. [2023]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. Characterisation of a human TDP-43 Q331K transgenic mouse ALS model reveals early motor decline, weight gain, and increased nuclear TDP-43 without canonical TDP-43 pathology, supporting its use as a powered preclinical model for ALS therapy testing. [2021]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

5. The study creates and characterizes transgenic mice overexpressing human TDP-43 with the M337V mutation under the mouse prion promoter, revealing that high levels of TDP-43 drive neuronal dysfunction, mitochondrial abnormalities, ubiquitination and gliosis, tau phosphorylation, and early death, with phenotypes largely overlapping those seen in wild-type TDP-43 overexpression and suggesting toxicity is driven by TDP-43 overexpression rather than the mutation alone. [2011]

9QualityResults Limitations Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Splicing-monomerization feedback (TDP-DiLuc) provides the mechanistic bridge by which TDP-43 loss could unmask cryptic polyA sites, but the supplied evidence never tests polyA-site usage directly — the causal chain has a missing link.

Hypothesis Graveyard

TDP-43 aggregation is the primary toxic driver: monomerization precedes aggregation in ActD timecourses, and Q331K mice show motor decline without canonical inclusions.

M337V mutation-specific toxicity: overexpression of WT TDP-43 recapitulates the same phenotypes in transgenic mice.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data may overweight mainstream ALS aggregation narratives, underweighting less-cited cryptic RNA-processing literature not present in the supplied records.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Missing Direct Evidence: APA/Cryptic PolyA

Top Data Sources Export MCP

4. Characterisation of a human TDP-43 Q331K transgenic mouse ALS model reveals early motor decline, weight gain, and increased nuclear TDP-43 without canonical TDP-43 pathology, supporting its use as a powered preclinical model for ALS therapy testing. [2021]

6. Glycogen synthase kinase-3 (GSK3) inhibition dampens caspase-dependent TDP-43 fragmentation, reduces nuclear TDP-43 depletion, and enhances neuronal survival across rat, mouse, and human iPSC-derived neurons, revealing a therapeutic GSK3–TDP-43 axis in ALS-FTD models. [2026]

11. Phosphorylation at TDP-43 serines 409/410 drives neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy, with phosphorylation removal rescuing mutant TDP-43–induced motor deficits and neurodegeneration. [2010]

Ask a Follow-Up

Key Insight

Splicing-monomerization feedback (TDP-DiLuc) provides the mechanistic bridge by which TDP-43 loss could unmask cryptic polyA sites, but the supplied evidence never tests polyA-site usage directly — the causal chain has a missing link.

Hypothesis Graveyard

TDP-43 aggregation is the primary toxic driver: monomerization precedes aggregation in ActD timecourses, and Q331K mice show motor decline without canonical inclusions.

M337V mutation-specific toxicity: overexpression of WT TDP-43 recapitulates the same phenotypes in transgenic mice.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data may overweight mainstream ALS aggregation narratives, underweighting less-cited cryptic RNA-processing literature not present in the supplied records.

Stay current without chasing every paper.

My BGPT

Trending

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Missing Direct Evidence: APA/Cryptic PolyA

Top Data Sources ExportMCP

4. Characterisation of a human TDP-43 Q331K transgenic mouse ALS model reveals early motor decline, weight gain, and increased nuclear TDP-43 without canonical TDP-43 pathology, supporting its use as a powered preclinical model for ALS therapy testing. [2021]

6. Glycogen synthase kinase-3 (GSK3) inhibition dampens caspase-dependent TDP-43 fragmentation, reduces nuclear TDP-43 depletion, and enhances neuronal survival across rat, mouse, and human iPSC-derived neurons, revealing a therapeutic GSK3–TDP-43 axis in ALS-FTD models. [2026]

11. Phosphorylation at TDP-43 serines 409/410 drives neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy, with phosphorylation removal rescuing mutant TDP-43–induced motor deficits and neurodegeneration. [2010]

Ask a Follow-Up

Key Insight

Splicing-monomerization feedback (TDP-DiLuc) provides the mechanistic bridge by which TDP-43 loss could unmask cryptic polyA sites, but the supplied evidence never tests polyA-site usage directly — the causal chain has a missing link.

Hypothesis Graveyard

TDP-43 aggregation is the primary toxic driver: monomerization precedes aggregation in ActD timecourses, and Q331K mice show motor decline without canonical inclusions.

M337V mutation-specific toxicity: overexpression of WT TDP-43 recapitulates the same phenotypes in transgenic mice.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data may overweight mainstream ALS aggregation narratives, underweighting less-cited cryptic RNA-processing literature not present in the supplied records.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP